Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/TRCγδ+) and DERL-7 (CD56+/CD3-/TCRκγδ-), derived from a single patient with CD56+ non-Hodgkin's lymphoma

Leukemia

Volumn 15, Issue 10, 2001, Pages 1641-1649

  Noto, R Di ^a   Pane, F ^a   Camera, A ^a   Luciano, L ^a   Barone, M ^a   Pardo, C Lo ^b   Boccuni, P ^b   Intrieri, M ^c   Izzo, B ^a   Villa, M R ^a   Macri M ^b   Rotoli, B ^a   Sacchetti, L ^a   Salvatore, F ^a   Del Vecchio, L ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

^c UNIVERSITY OF MOLISE   (Italy)

Author keywords

CD56; Cell lines; DERL 2; DERL 7; Non Hodgkin's lymphoma; TCR

Indexed keywords

BLEOMYCIN; CD158B ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOKINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; IDARUBICIN; IFOSFAMIDE; INTERLEUKIN 2; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ASPIRATION BIOPSY; CANCER CELL CULTURE; CASE REPORT; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL STRAIN DERL2; CELL STRAIN DERL7; CHROMOSOME 10; CHROMOSOME 4; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME LOSS; CONTROLLED STUDY; DEATH; DIPLOIDY; FLOW CYTOMETRY; GENE LOCUS; GENE REARRANGEMENT; GENOTYPE; HUMAN; HUMAN CELL; KARYOTYPING; LIVER; MALE; MALIGNANT NEOPLASTIC DISEASE; METAPHASE; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SPLEEN; TANDEM REPEAT;

EID: 0034783070     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402239     Document Type: Article

References (47)

1. Development of human T and natural killer cells
2. Biology and clinical relevance of human natural killer cells
3. Classification of natural killer (NK) cell and NK-like T-cell malignancies
4. Clonal disease of large granular lymphocytes
5. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
6. + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas
7. + non-Hodgkin lymphomas with an aggressive behavior related to multidrug resistance
8. Natural killer-like T-cell lymphomas: Aggressive lymphomas of T-large granular lymphocytes
9. + aggressive variant of large granular lymphocyte leukemia
10. Hepatosplenic T-cell lymphoma: Sinusal/sinusoidal localization of malignant cell expressing the T-cell receptor γδ
11. + lymphoma/leukemia
12. Guidelines for the characterization and publication of human malignant hematopoietic cell lines
13. +) cell lines: 'Two sided' model for investigating leukemic megakayocytopoiesis
14. Allele frequency distributions at several variable number of tandem repeat (VNTR) and short tandem repeat (STR) loci in a restricted Caucasian population from south Italy and their evaluation for paternity and forensic use
15. Efficiency of two different nine-loci short tandem repeat systems for DNA typing purposes
16. A rapid banding technique for human chromosomes
17. A novel mechanism of somatic rearrangement predicted by a human T-cell antigen receptor β-chain complementary DNA
18. Human T-cell γ-chain genes: Organization, diversity and rearrangement
19. The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor Cδ locus on human chromosome 14q11 and a transcribed region of chromosome 11q15
20. High incidence of Epstein-Barr virus genomes in Hodgkin's disease
21. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C-reactive protein correlate with exacerbation of multicentric Castelman disease in HIV-infected patients
22. human herpesvirus 8 infections in the Amsterdam cohort studies (1984-1997): Analysis of seroconversion to ORF65 and ORF73
23. Detection and characterization of human T-cell lymphotropic virus type 1 (HTLV-I) associated T-cell neoplasm in an HTLV-I nonendemic region by plymerase chain reaction
24. Cytofluorometric methods for assessing absolute numbers of cell subsets in blood
25. Natural killer function in flow cytometry. I. Evaluation of NK lytic activity on K562 cell line
26. Malignant hematopoietic cell lines: In vitro models for the study of natural killer cell leukemia-lymphoma cell lines
27. CD69 Workshop Panel report
28. CD26 Workshop Panel report
29. CD26 expression and dipeptidyl peptidase IV activity in an aggressive hepatosplenic T-cell lymphoma
30. Human NK cells: Their ligands, receptors and functions
31. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles
32. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 displaying different specificities
33. Expression of a functional c-kit receptor on a subset of natural killer cells
34. Isochromosome 7 q: The primary cytogenetic abnormality in hepatosplenic γδ T cell lymphoma
35. Consistent presence of isochromosome 7 q in hepatosplenic T γδ lymphoma: A new cytogenetic-clinicopathologic entity
36. Hepatosplenic γδ T cell lymphoma: Cytogenetic abnormalities may predict clinical outcome
37. Identification of del(6) (q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukaemia
38. Synergistic action of interleukin-2 and Steel factor (SLF) on a human T lymphoblastoid cell line
39. Stem cell factor enhances interleukin-2-mediated expansion of murine natural killer cells in vivo
40. Stable transduction of the interleukin-2 gene into natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo
41. The receptor tyrosine kinase c-kit provides a critical signal for survival, expansion, and maturation of mouse natural killer cells
42. Establishment of a new natural killer (NK) cell line, TKS-1, from a patient with aggressive type of large granular lymphocyte (LGL) leukemia
43. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells
44. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection